pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,770 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT786Endpoints591BioPharma Dive228onclive165BioSpace63Fierce Biotech63raps25
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • Biopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and more
    Welcome back to Endpoints Weekly! This week, we opened nominations for our eighth annual Women in Biopharma report. We’re looking to profile 20 scientists, executives, founders and other enterprisi…
    Endpoints · 1mo ago↗ source
  • Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73
    "There are some physicians that work to 100”: Dawn Zuidgeest-Craft on becoming a medical doctor in her 70s.
    STAT · 1mo ago↗ source
  • STAT+: Trump administration revisits policy to close Medicare drug price negotiation loophole
    Trump administration revisits policy to plug Medicare drug price negotiation loophole.
    STAT · 1mo ago
← prev
page 28 of 71
next →
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
↗ source
  • Merck brings Welireg-Keytruda combo to treat kidney cancer
    Merck’s Welireg and Keytruda combination won approval as an adjuvant treatment for kidney cancer patients after surgery to remove all or part of the organ. The combination was approved Friday for…
    Endpoints · 1mo ago↗ source
  • Amgen and the FDA want two different outcomes for Tavneos. What will patients do?
    Amgen has asked the FDA to review evidence that its drug Tavneos (avacopan), which treats a rare form of vasculitis, is worth keeping on the market, as the future of the drug remains in flux. ...
    Endpoints · 1mo ago↗ source
  • Eli Lilly invests in startup Abridge for clinical trial recruitment
    Eli Lilly has invested in Abridge as the health tech startup expands into clinical trial recruitment and broadens its reach into the life sciences. The investment, made through Lilly’s venture ar…
    Endpoints · 1mo ago↗ source
  • STAT+: Up and down the ladder: The latest comings and goings
    From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
    STAT · 1mo ago↗ source
  • Enliven prices $400M offering; Jazz drug Zepzelca fails confirmatory study
    Plus news about Caribou, Adial, and the Beneluxa Initiative. 💵 Enliven Therapeutics’ data and raise: The Burlingame, CA-based biotech priced a $400 million offering {$ELVN} Thursday night after…
    Endpoints · 1mo ago↗ source
  • STAT+: Prometheus raises $12 billion in capital for artificial engineers
    Nonprofit Blood Cancer United acquires cancer drug, Lilly and Nvidia invest in Abridge, and more biotech news
    STAT · 1mo ago↗ source
  • Biopharma's pay oddities of 2025: Executive perks and eccentricities
    In combing through thousands of C-suite pay packages worth billions of dollars, it’s rare for a line item to stick out. Every once in a while, a biopharma company discloses perks that go beyond t…
    Endpoints · 1mo ago↗ source
  • Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
    <p>In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor syndicate and why the company is confident it can join the ranks of successful, commercial-stage brain drugmakers.</p>
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more
    The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta
    STAT · 1mo ago↗ source
  • Chile offers new data on food warning label efficacy
    Kennedy's "publicly" "available" "calendar," drinking during pregnancy, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military list
    WuXi AppTec has lodged a claim against the Department of Defense following its addition to a list of companies associated with the Chinese military. Under the complaint, filed Thursday with the U…
    Endpoints · 1mo ago↗ source
  • GSK took advantage of ASCO dip to get discount on Nuvalent
    GSK’s $10.6 billion buyout of Nuvalent, announced Tuesday, was the largest in the company’s history. But did new CEO Luke Miels get a discount? At $124 a share, the price Miels paid ...
    Endpoints · 1mo ago↗ source
  • Novo's M&A leader leaves for Forbion; Perrigo CEO's 'personal conduct' issues led to resignation
    Forbion’s portfolio companies have been no stranger to M&A deals in recent years. But the Dutch investment firm now wants more of its biotechs to benefit from the industry’s ...
    Endpoints · 1mo ago↗ source
  • Sciwind has two Western partners for its obesity drug, but is open to more
    Sciwind Biosciences has already licensed its GLP-1 obesity drug ecnoglutide twice over — to Pfizer and Verdiva Bio — but it is not done yet. The Chinese biotech is seeking new partners for the ri…
    Endpoints · 1mo ago↗ source
  • Opinion: I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule
    “American science is too valuable to be turned into a political football,” writes David J. Skorton, president of the Association of American Medical Colleges.
    STAT · 1mo ago↗ source
  • Opinion: Ebola outbreak response requires engaging with religious traditions and leaders
    “Failing to engage religious and traditional leaders in meaningful ways was a grave misstep in previous Ebola outbreaks,” researchers write.
    STAT · 1mo ago↗ source
  • STAT+: At hospital finance conference, a call to end the friction that’s keeping costs high
    Hospital execs agree that affordability is a major issue. What to do about it is less clear.
    STAT · 1mo ago↗ source
  • How a diabetes conference sparked a controversy
    Many in the diabetes research community expressed shock and disbelief that their colleagues were threatened with arrest for passing out paper copies of an editorial.
    STAT · 1mo ago↗ source
  • STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
    STAT is tracking goals and promises of Robert F. Kennedy Jr. and his Make America Healthy Again movement — successes, incompletes, and fails.
    STAT · 1mo ago↗ source
  • STAT+: An obesity drug deep-dive, and peptides move mainstream
    Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug Administration allow…
    STAT · 1mo ago↗ source
  • RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
    None of STAT's requests for Kennedy's schedule have been completed, and some haven't even been acknowledged.
    STAT · 1mo ago↗ source
  • Drinking during pregnancy rose after 2020, new CDC data suggest
    A new CDC report underscores that drinking during pregnancy, while generally thought of as a thing of the past, is still a matter of concern. 
    STAT · 1mo ago↗ source